Let us help you unveil a more youthful, confident, and radiant you
Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution
GLP-1 Meds: What They Really Do and What They Dont Before anyone decides to use GLP-1 medication, its essential to understand both the benefits and the limitations
That starting semaglutide or tirzepatide did not lower the risk of inflammatory bowel disease relapse in adults with stable IBD who also had obesity or diabetes, and did not raise safety events
No hay reseas de clientes en este momento.
A., Ekhzaimy, A., Masood, A., & Sakharkar, M